A new review in Virology Journal examines how siRNA and CRISPR/Cas gene-silencing technologies could target the HPV16 ...
Prioritize viral vectors, oncology and rare disease therapies, with North America offering strong ROI potential through regulatory support, R&D investment and early adoptionDublin, Oct. 08, 2026 ...
A $25 million gift from the Smilow Foundation, led by William Smilow, will establish the Smilow Center for Precision ...
CRISPR-Cas9 removed an extra chromosome 21 from some Down syndrome cells in the lab. Learn what the 30.6% result means and why treatment is still far away.
A comprehensive multi-omics study catalogues thousands of cancer-specific isoform switches in melanoma, ovarian cancer, and ...
Record global approvals, CRISPR breakthroughs, and expanding clinical and commercial activity are accelerating demand for cell and gene therapy tools and reagents.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE ...
DNA typewriter maps mouse embryo development to reveal disease origins Barcode trail tracks cell family trees to pinpoint ...
BioSpectrum India on MSN
Karnataka biosciences companies explore partnerships with Montana
CXO-level roundtable was facilitated by the Association of Biotechnology Led Enterprises (ABLE) ...
Zacks Investment Research on MSN
If you invested $1000 in Eli Lilly a decade ago, this is how much it'd be worth now
How much a stock's price changes over time is a significant driver for most investors. Not only can price performance impact your portfolio, but it can help you compare investment results across ...
Saudi Arabia's flagship biotech gathering is no longer a regional talking shop. The Riyadh Global Medical Biotechnology Summit closed its ...
The programme will test how data collected continuously from wearable devices can be combined with patients' clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results